{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:12:47Z","timestamp":1788631967828,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40615-025-02523-5","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T16:30:29Z","timestamp":1751041829000},"page":"3633-3639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disparities in Healthcare Providers\u2019 Substance Use Detection Practices for Pregnant Patients"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-0030","authenticated-orcid":false,"given":"Virginia","family":"Lijewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaylin","family":"Klie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunah S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanelle","family":"Sheeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"issue":"7","key":"2523_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s10995-021-03127-1","volume":"25","author":"SL Boden","year":"2021","unstructured":"Boden SL, Jones CW, Cabacungan ET. Improved maternal and infant outcomes with serial, self-reported early prenatal substance use screening. Matern Child Health J. 2021;25(7):1118\u201325.","journal-title":"Matern Child Health J"},{"key":"2523_CR2","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, Committee Opinion No. 711 Summary: Opioid use and opioid use disorder in pregnancy. Obstetrics & Gynecology, 2017. 130(2):488\u2013489.","DOI":"10.1097\/AOG.0000000000002229"},{"key":"2523_CR3","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, Committee Opinion No. 633: Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Obstetrics & Gynecology, 2015. 125(6): p. 1529\u20131537.","DOI":"10.1097\/01.AOG.0000466371.86393.9b"},{"key":"2523_CR4","doi-asserted-by":"crossref","unstructured":"Patrick, S.W. and D.M. Schiff, A public health response to opioid use in pregnancy. Pediatrics, 2017. 139(3).","DOI":"10.1542\/peds.2016-4070"},{"key":"2523_CR5","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. 2020 July 1, 2023]; Table 6.21B \u2013 Illicit Drug Use, Marijuana Use, and Opioid Misuse in Past Month: Among Females Aged 15 to 44; by Pregnancy Status, Demographic, Socioeconomic, and Pregnancy Characteristics, Percentages, 2019 and 2020]. Available from: https:\/\/www.samhsa.gov\/data\/report\/2020-nsduh-detailed-tables."},{"issue":"32","key":"2523_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.15585\/mmwr.mm6932a2","volume":"69","author":"JY Ko","year":"2020","unstructured":"Ko JY, et al. Characteristics of Marijuana Use During Pregnancy - Eight States, Pregnancy Risk Assessment Monitoring System, 2017. MMWR Morb Mortal Wkly Rep. 2020;69(32):1058\u201363.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2523_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ntt.2018.06.001","volume":"68","author":"VH Coleman-Cowger","year":"2018","unstructured":"Coleman-Cowger VH, et al. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol. 2018;68:84\u201390.","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"2523_CR8","first-page":"23","volume":"1","author":"PS Gupta","year":"2021","unstructured":"Gupta PS, et al. Higher Marijuana use among young adults persists even during pregnancy. J Gynaecol Obstet Adv. 2021;1(1):23\u20139.","journal-title":"J Gynaecol Obstet Adv"},{"issue":"12","key":"2523_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/1471-0528.15885","volume":"126","author":"CE Rodriguez","year":"2019","unstructured":"Rodriguez CE, et al. Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study. BJOG. 2019;126(12):1491\u20137.","journal-title":"BJOG"},{"key":"2523_CR10","doi-asserted-by":"publisher","first-page":"101262","DOI":"10.1016\/j.pmedr.2020.101262","volume":"20","author":"KR Skelton","year":"2020","unstructured":"Skelton KR, Hecht AA, Benjamin-Neelon SE. Women\u2019s cannabis use before, during, and after pregnancy in New Hampshire. Prev Med Rep. 2020;20:101262.","journal-title":"Prev Med Rep"},{"issue":"7","key":"2523_CR11","doi-asserted-by":"publisher","first-page":"e196471","DOI":"10.1001\/jamanetworkopen.2019.6471","volume":"2","author":"KC Young-Wolff","year":"2019","unstructured":"Young-Wolff KC, et al. Self-reported daily, weekly, and monthly Cannabis use among women before and during pregnancy. JAMA Netw Open. 2019;2(7):e196471.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"2523_CR12","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/s41372-022-01335-3","volume":"42","author":"BL Smith","year":"2022","unstructured":"Smith BL, et al. Rates of substance and polysubstance use through universal maternal testing at the time of delivery. J Perinatol. 2022;42(8):1026\u201331.","journal-title":"J Perinatol"},{"issue":"31","key":"2523_CR13","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","volume":"67","author":"SC Haight","year":"2018","unstructured":"Haight SC, et al. Opioid use disorder documented at delivery hospitalization - United States, 1999\u20132014. MMWR Morb Mortal Wkly Rep. 2018;67(31):845\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2523_CR14","doi-asserted-by":"crossref","unstructured":"Ko, J.Y., et al., Vital signs: prescription opioid pain reliever use during pregnancy - 34 U.S. Jurisdictions, 2019. MMWR Morb Mortal Wkly Rep, 2020. 69(28): p. 897\u2013903.","DOI":"10.15585\/mmwr.mm6928a1"},{"key":"2523_CR15","doi-asserted-by":"publisher","first-page":"109331","DOI":"10.1016\/j.drugalcdep.2022.109331","volume":"233","author":"S Nechuta","year":"2022","unstructured":"Nechuta S, et al. Trends, patterns, and maternal characteristics of opioid prescribing during pregnancy in a large population-based cohort study. Drug Alcohol Depend. 2022;233:109331.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2523_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.whi.2022.08.007","volume":"33","author":"AF Peahl","year":"2023","unstructured":"Peahl AF, et al. Variation in opioid prescribing after vaginal and cesarean birth: a statewide analysis. Womens Health Issues. 2023;33(2):182\u201390.","journal-title":"Womens Health Issues"},{"issue":"12","key":"2523_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11920-019-1110-4","volume":"21","author":"AL Tobon","year":"2019","unstructured":"Tobon AL, Habecker E, Forray A. Opioid use in pregnancy. Curr Psychiatry Rep. 2019;21(12):118.","journal-title":"Curr Psychiatry Rep"},{"key":"2523_CR18","doi-asserted-by":"publisher","first-page":"109872","DOI":"10.1016\/j.drugalcdep.2023.109872","volume":"247","author":"A Board","year":"2023","unstructured":"Board A, et al. Polysubstance use during pregnancy: the importance of screening, patient education, and integrating a harm reduction perspective. Drug Alcohol Depend. 2023;247:109872.","journal-title":"Drug Alcohol Depend"},{"key":"2523_CR19","unstructured":"Chang, G. and E. Rosenthal. Substance use during pregnancy: screening and prenatal care. 2023 May 2, 2023 July 1, 2023]; Available from: https:\/\/www.uptodate.com\/contents\/substance-use-during-pregnancy-screening-and-prenatal-care."},{"issue":"1","key":"2523_CR20","doi-asserted-by":"publisher","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"J Ecker","year":"2019","unstructured":"Ecker J, et al. Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine. Am J Obstet Gynecol. 2019;221(1):B5-b28.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2523_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajog.2016.06.038","volume":"215","author":"TE Wright","year":"2016","unstructured":"Wright TE, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016;215(5):539\u201347.","journal-title":"Am J Obstet Gynecol"},{"key":"2523_CR22","unstructured":"American College of Nurse Midwives. Position Statement Substance use disorders in pregnancy. 2018 May 14, 2023]; Available from: https:\/\/www.midwife.org\/acnm\/files\/acnmlibrarydata\/uploadfilename\/000000000052\/PS-Substance-Use-Disorders-in-Pregnancy-FINAL-20-Nov-18.pdf."},{"issue":"18","key":"2523_CR23","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1001\/jama.2018.16789","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(18):1899\u2013909.","journal-title":"JAMA"},{"issue":"22","key":"2523_CR24","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.8020","volume":"323","author":"AH Krist","year":"2020","unstructured":"Krist AH, et al. Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301\u20139.","journal-title":"JAMA"},{"issue":"1","key":"2523_CR25","doi-asserted-by":"publisher","first-page":"100453","DOI":"10.1016\/j.ajogmf.2021.100453","volume":"4","author":"NC Perlman","year":"2022","unstructured":"Perlman NC, Cantonwine DE, Smith NA. Racial differences in indications for obstetrical toxicology testing and relationship of indications to test results. Am J Obstet Gynecol MFM. 2022;4(1):100453.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"2523_CR26","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3389\/fphar.2018.00961","volume":"9","author":"HR Price","year":"2018","unstructured":"Price HR, Collier AC, Wright TE. Screening pregnant women and their neonates for illicit drug use: consideration of the integrated technical, medical, ethical, legal, and social issues. Front Pharmacol. 2018;9:961.","journal-title":"Front Pharmacol"},{"issue":"7","key":"2523_CR27","doi-asserted-by":"publisher","first-page":"100963","DOI":"10.1016\/j.ajogmf.2023.100963","volume":"5","author":"MR Siegel","year":"2023","unstructured":"Siegel MR, et al. Assessing the clinical utility of toxicology testing in the peripartum period. Am J Obstet Gynecol MFM. 2023;5(7):100963.","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"5","key":"2523_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/NMC.0000000000000843","volume":"47","author":"EL Merritt","year":"2022","unstructured":"Merritt EL, et al. Health care professionals\u2019 perceptions of caring for patients with substance use disorders during pregnancy. MCN Am J Matern Child Nurs. 2022;47(5):288\u201393.","journal-title":"MCN Am J Matern Child Nurs"},{"issue":"6","key":"2523_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.wombi.2018.11.009","volume":"32","author":"HT Oni","year":"2019","unstructured":"Oni HT, et al. Barriers to screening pregnant women for alcohol or other drugs: a narrative synthesis. Women Birth. 2019;32(6):479\u201386.","journal-title":"Women Birth"},{"issue":"2","key":"2523_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/00221465211058152","volume":"63","author":"K McCabe","year":"2022","unstructured":"McCabe K. Criminalization of care: drug testing pregnant patients. J Health Soc Behav. 2022;63(2):162\u201376.","journal-title":"J Health Soc Behav"},{"key":"2523_CR31","doi-asserted-by":"crossref","unstructured":"Lijewski, V.A., H. Aldrich, and H.L. Straub, The impact of social vulnerability on substance use detection practices in pregnancy. Am J Perinatol, 2024.","DOI":"10.1055\/s-0044-1782686"},{"issue":"2","key":"2523_CR32","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11205-014-0698-3","volume":"122","author":"K Bergstrand","year":"2015","unstructured":"Bergstrand K, et al. Assessing the relationship between social vulnerability and community resilience to hazards. Soc Indic Res. 2015;122(2):391\u2013409.","journal-title":"Soc Indic Res"},{"key":"2523_CR33","doi-asserted-by":"crossref","unstructured":"Flanagan, B.E., et al., A social vulnerability index for disaster management. Journal of Homeland Security and Emergency Management, 2011. 8(1).","DOI":"10.2202\/1547-7355.1792"},{"issue":"3","key":"2523_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/ACM.0000000000001294","volume":"92","author":"P Bourgois","year":"2017","unstructured":"Bourgois P, et al. Structural vulnerability: operationalizing the concept to address health disparities in clinical care. Acad Med. 2017;92(3):299\u2013307.","journal-title":"Acad Med"},{"key":"2523_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1472-6963-13-94","volume":"13","author":"C Grabovschi","year":"2013","unstructured":"Grabovschi C, Loignon C, Fortin M. Mapping the concept of vulnerability related to health care disparities: a scoping review. BMC Health Serv Res. 2013;13:94.","journal-title":"BMC Health Serv Res"},{"key":"2523_CR36","unstructured":"Agency for Toxic Substances and Disease Registry. CDC SVI Documentation 2020. 2020 August 5, 2022 July 4, 2023]; Available from: https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/documentation\/SVI_documentation_2020.html."},{"issue":"2","key":"2523_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, et al. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"12","key":"2523_CR38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/01.mlr.0000233684.27657.36","volume":"44","author":"TD Denberg","year":"2006","unstructured":"Denberg TD, et al. The influence of patient race and social vulnerability on urologist treatment recommendations in localized prostate carcinoma. Med Care. 2006;44(12):1137\u201341.","journal-title":"Med Care"},{"issue":"1","key":"2523_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12874-021-01247-4","volume":"21","author":"J Sheringham","year":"2021","unstructured":"Sheringham J, Kuhn I, Burt J. The use of experimental vignette studies to identify drivers of variations in the delivery of health care: a scoping review. BMC Med Res Methodol. 2021;21(1):81.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2523_CR40","doi-asserted-by":"publisher","first-page":"e057095","DOI":"10.1136\/bmjopen-2021-057095","volume":"12","author":"D Tremblay","year":"2022","unstructured":"Tremblay D, et al. Development and use of research vignettes to collect qualitative data from healthcare professionals: a scoping review. BMJ Open. 2022;12(1):e057095.","journal-title":"BMJ Open"},{"issue":"2","key":"2523_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijchp.2014.12.001","volume":"15","author":"SC Evans","year":"2015","unstructured":"Evans SC, et al. Vignette methodologies for studying clinicians\u2019 decision-making: validity, utility, and application in ICD-11 field studies. Int J Clin Health Psychol. 2015;15(2):160\u201370.","journal-title":"Int J Clin Health Psychol"},{"issue":"2","key":"2523_CR42","first-page":"2134","volume":"8","author":"F Erfanian","year":"2020","unstructured":"Erfanian F, et al. A narrative on using vignettes: its advantages and drawbacks. Journal of Midwifery and Reproductive Health. 2020;8(2):2134\u201345.","journal-title":"Journal of Midwifery and Reproductive Health"},{"key":"2523_CR43","doi-asserted-by":"crossref","unstructured":"Atzm\u00fcller, C. and P.M. Steiner, Experimental vignette studies in survey research. Methodology: European Journal of Research Methods for the Behavioral and Social Sciences, 2010. 6(3): p. 128\u2013138.","DOI":"10.1027\/1614-2241\/a000014"},{"key":"2523_CR44","first-page":"1","volume":"145","author":"SG Uddin","year":"2014","unstructured":"Uddin SG, Simon AE, Myrick K. Routine prenatal care visits by provider specialty in the United States, 2009\u20132010. NCHS Data Brief. 2014;145:1\u20138.","journal-title":"NCHS Data Brief"},{"issue":"4","key":"2523_CR45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1370\/afm.1510","volume":"11","author":"KB Kozhimannil","year":"2013","unstructured":"Kozhimannil KB, Fontaine P. Care from family physicians reported by pregnant women in the United States. Ann Fam Med. 2013;11(4):350\u20134.","journal-title":"Ann Fam Med"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02523-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-025-02523-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-025-02523-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:39:50Z","timestamp":1788629990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-025-02523-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2523"],"URL":"https:\/\/doi.org\/10.1007\/s40615-025-02523-5","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the University of Colorado\u2019s Institutional Review Board (COMIRB # 22\u20130929).","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Those who accessed the survey were notified via COMIRB postcard consent that completion of the survey questions indicated consent to participate in the research.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}